Atara Biotherapeutics Inc. (NASDAQ: ATRA) Stock Information | RedChip

Atara Biotherapeutics Inc. (NASDAQ: ATRA)


$10.8800
+0.9500 ( +4.31% ) 63.7K

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Market Data


Open


$10.8800

Previous close


$9.9300

Volume


63.7K

Market cap


$60.07M

Day range


$9.9250 - $11.2050

52 week range


$6.5000 - $39.5000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 06, 2024
4 Insider transactions 1 Mar 06, 2024
4 Insider transactions 1 Mar 06, 2024
8-k 8K-related 12 Feb 23, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
8-k 8K-related 16 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024

Latest News